当前位置: 首页 > 期刊 > 《中国现代医生》 > 2018年第27期
编号:13275442
坦度螺酮联合氟西汀对抑郁症患者疗效和性功能的影响(4)
http://www.100md.com 2018年9月25日 《中国现代医生》 2018年第27期
     [22]姚琳,潘丽红. 坦度螺酮辅助治疗难治性抑郁症疗效及安全性观察[J].海南医学,2015,26(5):3-5.

    [23]Murata Y,Yanagihara Y,Mori M,et al. Chronic treatment with tandospirone,a serotonin 1A receptor partial agonist,inhibits psychosocial stress-induced changes in hippocampal neurogenesis and behavior[J]. J Affect Disord,2015,180(1-9):62.

    [24]Mori M,Murata Y,Matsuo A,et al. Chronic treatment with the 5-HT1A receptor partial agonist tandospirone increases hippocampal neurogenesis[J]. Neurol Ther,2014, 3(1):67-77.

    [25]Kim Van Rooij,Saskia Poels,Petra Worst,et al. Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin(1A) receptor agonist in women with SSRI-induced sexual dysfunction.A preliminary study[J]. European Journal of Pharmacology, 2015,75(3):246-251.

    [26]董琳琳,焦華丹.丁螺环酮治疗新型抗抑郁药物引起的性功能障碍临床研究[J].中国现代药物应用,2013,7(4):80.

    [27]Montejo AL,Llorca G,Izquierdo JA,et al. Incidence of sexual dysfunction associated with antidepressant agents: A prospective multicenter study of 1022 outpatients[J]. J Clin Psychiatry,2001,62(3):10-21.

    (收稿日期:2018-03-11), http://www.100md.com(周玲 张鹏 黄建龙)
上一页1 2 3 4